Yale University

Can life expectancy and QALYs be improved by a framework for deciding whether to apply clinical guidelines to patients with severe comorbid disease?

TitleCan life expectancy and QALYs be improved by a framework for deciding whether to apply clinical guidelines to patients with severe comorbid disease?
Publication TypeJournal Article
Year of Publication2011
AuthorsBraithwaite, Scott R.
JournalMedical decision making : an international journal of the Society for Medical Decision Making
Volume31
Issue4
Pagination582-95
Date Published2011 Jul-Aug
ISSN1552-681X
KeywordsBlood Glucose, Colorectal Neoplasms, Comorbidity, Female, Humans, Life Expectancy, Middle Aged, Models, Theoretical, Practice Guidelines as Topic, Quality-Adjusted Life Years
AbstractGuidelines with short-term harms and long-term benefits are often applied to chronically ill patients who may not benefit. The payoff time framework has been proposed (i.e., do not apply a guideline if a patient's life expectancy (LE) is shorter than when a guideline's cumulative incremental benefits first exceed its cumulative incremental harms), but its health impact is unclear.
DOI10.1186/1758-2652-14-38
Alternate JournalMed Decis Making

External Links